Challenges in estimation of glycated hemoglobin in India
- PMID: 23944907
- PMCID: PMC3781113
- DOI: 10.1089/dia.2013.0144
Challenges in estimation of glycated hemoglobin in India
Abstract
Glycated hemoglobin (HbA1c) is the most widely accepted index of long-term glycemic control. However, there are some clinical situations that make the accurate measurement of HbA1c difficult. Although some of these situations are general, others are more specific to some parts of the world like India. These conditions include hemoglobinopathies such as thalassemias and structural hemoglobin (Hb) variants such as HbS and HbD, as well as iron-deficiency anemia and the use of certain drugs. Because of the relatively frequent occurrence of some of these conditions in some parts of India, it is important that they are looked for when evaluating an inappropriately high or low HbA1c level. Alternative indices may have to be used for assessing glycemic control in these cases.
References
-
- The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. - PubMed
-
- Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853. - PubMed
-
- World Health Organization: Use of Glycated Hemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of WHO Consultation. Geneva: World Health Organization; 2011. - PubMed
-
- NGSP Certified Methods and Laboratories. www.ngsp.org. [May 24;2013 ]. www.ngsp.org
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical